JPWO2023074894A1 - - Google Patents

Info

Publication number
JPWO2023074894A1
JPWO2023074894A1 JP2023556701A JP2023556701A JPWO2023074894A1 JP WO2023074894 A1 JPWO2023074894 A1 JP WO2023074894A1 JP 2023556701 A JP2023556701 A JP 2023556701A JP 2023556701 A JP2023556701 A JP 2023556701A JP WO2023074894 A1 JPWO2023074894 A1 JP WO2023074894A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023556701A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023074894A1 publication Critical patent/JPWO2023074894A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023556701A 2021-11-01 2022-10-31 Pending JPWO2023074894A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021179081 2021-11-01
PCT/JP2022/040711 WO2023074894A1 (ja) 2021-11-01 2022-10-31 軟骨再生促進剤

Publications (1)

Publication Number Publication Date
JPWO2023074894A1 true JPWO2023074894A1 (ru) 2023-05-04

Family

ID=86159513

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556701A Pending JPWO2023074894A1 (ru) 2021-11-01 2022-10-31

Country Status (3)

Country Link
JP (1) JPWO2023074894A1 (ru)
TW (1) TW202333660A (ru)
WO (1) WO2023074894A1 (ru)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8394856B2 (en) * 2002-07-02 2013-03-12 Glykon Technologies Group, Llc (-)-Hydroxycitric acid for controlling inflammation
US20060025483A1 (en) * 2004-07-29 2006-02-02 Clouatre Dallas L (-)-Hydroxycitric acid for protection against soft tissue and arterial calcification
ITTO20060580A1 (it) * 2006-08-04 2008-02-05 Rottapharm Spa Preparazioni per somministrazione orale aventi effetti salutistici sugli apparati osteoarticolare e muscoloscheletrico
JP2014129252A (ja) * 2012-12-28 2014-07-10 Nof Corp 皮膚機能改善剤
IL294063B1 (en) * 2014-07-29 2024-08-01 Shenzhen Hightide Biopharmaceutical Ltd Salts of berberic acid, salts of ursodeoxycholic acid and their combinations, methods for their preparation and their uses
JP6280076B2 (ja) * 2015-03-31 2018-02-14 株式会社東洋新薬 オシダ科植物含有組成物
EP3509578B1 (en) * 2016-09-08 2022-12-21 Glykon Technologies Group, LLC Monomeric bimetal hydroxycitric acid compounds and methods of making and using the same

Also Published As

Publication number Publication date
TW202333660A (zh) 2023-09-01
WO2023074894A1 (ja) 2023-05-04

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ru)
BR112021014123A2 (ru)
BR112022009896A2 (ru)
BR112023009656A2 (ru)
BR112022024743A2 (ru)
BR112023006729A2 (ru)
BR102021018859A2 (ru)
BR102021015500A2 (ru)
BR102021007058A2 (ru)
BR112023008622A2 (ru)
BR112023011738A2 (ru)
BR112023004146A2 (ru)
BR112023011539A2 (ru)
BR112023008976A2 (ru)
JPWO2022085603A1 (ru)
BR102021020147A2 (ru)
BR102021018926A2 (ru)
BR102021018167A2 (ru)
BR102021017576A2 (ru)
BR102021016837A2 (ru)
BR102021016551A2 (ru)
BR102021016375A2 (ru)
BR102021016200A2 (ru)
BR102021016176A2 (ru)
BR102021015566A2 (ru)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240501